EpiVax: Amsterdam Immunogenicity & Tolerance Seminar


After a postponement due to COVID travel restrictions, EpiVax is pleased to announce new dates for this year’s Amsterdam Immunogenicity & Tolerance Seminar!

The seminar is now a two-day, afternoon-only format. This arrangement leaves mornings free for attendees to network, collaborate in small groups, and enjoy the beautiful city of Amsterdam.

All events will take place at the Hilton Apollolaan. Apollolaan 138, 1077 BG, Amsterdam, Netherlands


Day 1, Thursday, November 4th12:00 PM- 6 PM CET (Central European Time)

  • Lunch will be provided from 12-1 PM
  • Seminar talks will go from 1pm -6 PM
  • Cocktail reception from 6 – 8 PM

Day 2, Friday November 5th1 PM – 5 PM CET (Central European Time)

  • Lunch will provided from 12-1 PM
  • Seminar talks will go from 1 PM – 5 PM

The seminar will focus on translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.

Interested in attending this free event? Register here! 

We are so excited to return to Amsterdam and meet safely and responsibly with our colleagues for this in-person event. Please note that we will be monitoring the COVID-19 pandemic and travel restrictions, and we will communicate any changes in advance if the events cannot safely take place.

Special Guest Speakers will include:


  • Guilhem Richard, Ph.D. Lead Computational Immunologist, EpiVax Therapeutics
  • Corine Kruiswijk, Ph.D. Project Manager, Intravacc
  • Bram Slutter, Ph.D. Associate Professor, Leiden University
  • Willem van Eden, Ph.D. Professor Emeritus in Immunology, Utrecht University
  • Onur Özer, PhD Fellow, Max Planck Institute for Evolutionary Biology


  • Naomi Benne, Ph.D. Postdoctoral Researcher, Utrecht University
  • Florian Deissenhammer, MD. Professor of Neurology,  Medical University of Innsbruck
  • Amy Rosenberg , MD. Senior Director of Immunology and Protein Therapeutics, EpiVax

More information & registration

For more information and registration, please see the event website.

Source: EpiVax

‹ Events overview